Reach out to South America with QED

With a population of over 500 million people, concentrated around major cities, Latin America continues to be a focus area for clinical research.

The region offers many advantages for conducting clinical trials, including:

Large, heterogeneous population
Treatment-naive patients
Highly trained medical staff
Strong enrolment rates – in some cases 3-5 times greater than US & Western Europe
Excellent patient retention – approximately 30% less discontinuations versus US & Western Europe
Well-trained, eager & available Investigators & Clinical Study Staff
Highly competitive clinical trial costs
Solid Regulatory framework with reliable processes and predictable timelines in most countries
Established infrastructure with Clinical Trial experienced Investigators
Seasonal disease prevalence all year around in some countries allows for extended recruitment advantage

Our Therapeutic Experience